Excipients & Specialty Ingredients
Company Overview
About
allozymes is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Singapore
Founded:2013
Employees:2,624
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval W13YA7
EMA · #APR-3CH2TVUV · 2018-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
WHO GMP
World Health Organization
Cert #: CERT-4HA4RA71
Issued: 2020-06-09
Expires: 2025-04-05
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-YL6N19IO
Issued: 2020-09-18
Expires: 2025-01-25
Loading CDMO intelligence...
Key facts about allozymes
- allozymes is headquartered in Singapore.
- allozymes was founded in 2013.
- allozymes has 2,624 employees.
- allozymes's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like allozymes
Directory pages this company appears in, each with the full list of matching manufacturers.